ARCHIVES

Rituximab After CVP Improves Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

House DoD Report Provides $15 Million For Lung Cancer Screening

October 23, 2009

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009